Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bolus Norepinephrine Administration and Fetal Acidosis at Cesarean Delivery Under Spinal Anesthesia.

Anesthesia and analgesia·2018
Same author

Possible influence of decreasing maternal ephedrine requirements on fetal/maternal concentration ratio at delivery.

Anesthesiology·2010
Same author

Effect of vasopressors on systolic, mean and diastolic arterial pressure during spinal anaesthesia in pregnancy.

International journal of obstetric anesthesia·2007
Same author

Impact of changing from ephedrine to phenylephrine as the first-line vasopressor during urgent caesarean section.

International journal of obstetric anesthesia·2006
Same author

Hypotension and intraoperative nausea and vomiting during regional anesthesia for cesarean section.

International journal of obstetric anesthesia·2006
Same author

Evidence that intravenous vasopressors can affect rostral spread of spinal anesthesia in pregnancy.

Anesthesiology·2004

Related Experiment Video

Updated: May 23, 2026

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus
11:59

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus

Published on: April 28, 2023

Caesarean delivery vasopressor management.

David W Cooper1

  • 1Department of Anaesthesia, James Cook University Hospital, Middlesbrough, Cleveland, UK. drdavidcooper@aol.com

Current Opinion in Anaesthesiology
|April 5, 2012
PubMed
Summary

Phenylephrine is the preferred vasopressor for preventing hypotension during cesarean delivery spinal anesthesia. Careful administration is key to avoid hypertension and ensure maternal-fetal safety.

Area of Science:

  • Anesthesiology
  • Obstetrics
  • Pharmacology

Background:

  • Spinal anesthesia for cesarean delivery can cause hypotension due to decreased systemic vascular resistance.
  • Vasopressors are crucial for managing this hemodynamic instability.
  • Recent findings emphasize the safety and efficacy of specific vasopressors.

Purpose of the Study:

  • To review maternal and fetal effects of vasopressor use during spinal anesthesia for cesarean delivery.
  • To highlight recent advancements and clinical considerations in vasopressor therapy.

Main Methods:

  • Systematic review of current literature on vasopressor administration.
  • Analysis of maternal hemodynamics, fetal outcomes, and adverse events.
  • Evaluation of different vasopressor agents and their regimens.

Related Experiment Videos

Last Updated: May 23, 2026

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus
11:59

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus

Published on: April 28, 2023

Main Results:

  • Phenylephrine is effective in preventing hypotension, with no observed adverse maternal or fetal effects despite potential cardiac output reduction.
  • Prophylactic phenylephrine can lead to hypertension if infusion rates are not adjusted.
  • Ephedrine response may vary based on fetal genotype; combined vasopressor and vagolytic therapy can cause hypertensive crises.

Conclusions:

  • Phenylephrine is the vasopressor of choice for preventing hypotension and nausea during cesarean delivery.
  • Optimized phenylephrine regimens are needed for safe, less frequent blood pressure monitoring.
  • Caution is advised with vasopressors when used concurrently with vagolytics for bradycardia.